Fusion Pharmaceuticals In...

NASDAQ: FUSN · Real-Time Price · USD
21.55
0.03 (0.14%)
At close: Jun 03, 2024, 10:00 PM

Fusion Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
28.26M 61.92M 26.79M 32.02M 53.62M 43.86M 106.05M 61.52M 59.21M 52.9M 38.38M 27.61M 41.07M
Short-Term Investments
182.74M 172.15M 164.56M 166.07M 156.23M 127.01M 99.43M 136.9M 137.6M 147.9M 154.24M 150.9M 186.15M
Long-Term Investments
73.43M 14.58M 15.93M 28.42M 11.34M 15.76M 1.02M 1.02M 9.9M 19.99M 45.55M 81.97M 51M
Other Long-Term Assets
652K 849K 2.32M 2.67M 6.31M 9.18M 8.67M 9.06M 9.36M 9.42M 9.01M 4.08M 1.74M
Receivables
4.68M 4.21M 2.37M 2.4M 2.54M 1.72M 2.92M 2.6M 1.69M 357K 2.29M 1.35M 979K
Inventory
n/a n/a 8.23M 5.67M -4.4M -9.87M 6.81M 5.51M 5.85M 10.38M 7.8M 5.06M 5.18M
Other Current Assets
5.24M 5.1M 1.32M 1.7M 1.3M 509K 635K 540K 422K 233K 311K 227K 478K
Total Current Assets
220.92M 243.4M 203.26M 207.86M 220.62M 179M 215.85M 207.07M 204.78M 211.76M 203.01M 185.16M 233.85M
Property-Plant & Equipment
24.45M 23.9M 24.98M 23.34M 22.98M 10.31M 9.82M 9.77M 9.94M 9.45M 9.41M 9.88M 10.06M
Goodwill & Intangibles
n/a -849K n/a n/a n/a n/a -1.02M -1.02M n/a n/a n/a n/a n/a
Total Long-Term Assets
102.9M 42.44M 50.11M 60.43M 45.93M 40.07M 22.65M 21.06M 31.18M 40.51M 65.29M 97M 63.45M
Total Assets
323.81M 285.84M 253.38M 268.29M 266.55M 219.06M 238.49M 228.13M 235.96M 252.27M 268.3M 282.16M 297.31M
Account Payables
2.5M 1.86M 1.06M 2.06M 1.9M 2.69M 1.31M 1.55M 1.77M 2.19M 3.8M 685K 1.02M
Deferred Revenue
333K 333K 727K 769K 768K 924K 412K 707K 1.1M 1.54M 2.29M 1.73M 1M
Short-Term Debt
4.29M 4.16M 6.17M 5.36M 4.64M 1.44M 1.43M 1.44M 1.43M 1.22M 1.33M 1.26M 1.19M
Other Current Liabilities
13.63M 9.86M 9.53M 8.91M 10.02M 10.01M 10.26M 7.88M 7.87M 7.56M 6.15M 5.68M 4.41M
Total Current Liabilities
20.76M 16.22M 17.48M 17.09M 17.32M 15.07M 13.41M 11.58M 12.18M 12.51M 13.56M 9.37M 7.62M
Long-Term Debt
49.69M 34.77M 46.46M 45.27M 45.43M 38.81M 38.98M 14.86M 5.55M 5.51M 5.78M 6.08M 6.32M
Other Long-Term Liabilities
301K 301K 299K 299K 299K 299K 297K 297K 297K 297K 295K 295K 295K
Total Long-Term Liabilities
61.23M 47.14M 47.43M 48.23M 48.39M 41.78M 41.94M 17.65M 8.35M 8.3M 8.24M 9.24M 10.62M
Total Liabilities
81.98M 63.36M 64.91M 65.33M 65.72M 56.84M 55.35M 29.23M 20.53M 20.82M 21.81M 18.61M 18.24M
Total Debt
64.55M 50.33M 52.63M 50.62M 50.06M 40.25M 40.41M 16.29M 6.99M 6.72M 7.11M 7.34M 7.52M
Common Stock
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Retained Earnings
-410.43M -376.76M -348.58M -331.33M -306.15M -281.86M -257.25M -233.23M -214.16M -194.25M -177.01M -157.59M -130.73M
Comprehensive Income
-582K 237K -841K -252K -85K -469K -1.26M -1.06M -578K -115K 63K 337K 283K
Shareholders Equity
241.83M 222.48M 188.47M 202.96M 200.83M 162.22M 183.14M 198.91M 215.43M 231.46M 246.5M 263.55M 279.07M
Total Investments
256.17M 186.74M 180.49M 194.5M 167.56M 142.77M 99.43M 136.9M 147.5M 167.88M 199.79M 232.88M 237.15M